Atlas Trials

Takara Bio Inc.

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Takara Bio Inc.

RecordFirmDate
Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma (NCT07174427)Takara Bio Inc.2026-01-05
Phase I Study of TBI-1401(HF10) Plus Chemotherapy in Patients with Unresectable Pancreatic Cancer. (NCT03252808)Takara Bio Inc.2017-09-25
Study of TBI-1301 (NY-ESO-1 T Cell Receptor Gene Transduced Autologous T Lymphocytes) in Patients with Synovial Sarcoma (NCT03250325)Takara Bio Inc.2017-09-20

Track Takara Bio Inc. automatically

Every clearance here is in the API, with alerts when new ones post.